Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes
"If you are increasing the protein, you're decreasing the rapidly absorbable carbohydrates, you're decreasing fat, excess calories, and sugar," says Kessler
"And that is, when you stop the microdosing, you will gain the weight back." That is also often the case when patients stop taking full doses of GLP-1 drugs
Specifically, we do not know what component of GLP-1 effects is attributable not to risk factor modulation, but rather to processes acting directly on the heart
However, in comparison to vehicle-treated mice, mice treated with GLP-1MK-801 demonstrated a slight decrease in plasma glucagon levels (Extended Data Fig
Available in brand-name and compounded forms, semaglutide supports GLP-1 activity and is widely used for weight management